The journey to mass spectrometry (LC-MS/MS) adoption from immunoassay can be complicated, but certainly rewarding. While immunoassay has been considered the default methodology for decades, they can be susceptible to…

Are you thinking about replacing existing immunoassay technology with clinical mass spectrometry?  Keep reading to discover how the 3 “S”s will help you make the decision. 1. How does sensitivity play a…

Featuring: Wake Forest® Baptist Health Steven Wong, Ph.D., DABCC (TC), FACB, Past President AACC, Professor of Pathology, serves as Director of the Clinical Chemistry and Toxicology Core Laboratory and is Co-director…

Aaron Hudson, VP/GM, Clinical Diagnostics, SCIEX Aaron Hudson is Vice President and General Manager, Clinical Diagnostics at SCIEX. Aaron has been with SCIEX for over 17 years, beginning as a…

We would like to formally (or informally) introduce the new SCIEX Clinical Diagnostics blog series entitled, Take 5. Every couple of months we will ask a member of our team to…

According to the American Clinical Laboratory Association, more than 7 billion clinical lab tests are performed in the U.S. every year. While mass spectrometry represents only a fraction of the clinical applications,…

Last month, Dr. Phil Levy, a clinician, professor, and researcher at Wayne State University, was invited to SCIEX to lecture on ‘Vitamin D Measurement and Implications for Patient Care.' His message was…

If you work in clinical diagnostics, you can probably confirm that most clinical laboratories have seen a 5 to 6-fold increase in 25-hydroxyvitamin D testing over the past decade, and…

Welcome to the first post in our clinical diagnostic blog series. Our ambition is to become your single destination for everything mass spec in the clinical diagnostic lab. To make…